Notably, ERCC6L was considered to be a poor prognosis marker that promotes cancer cell proliferation, migration and/or invasion, with aberrantly high expression in a wide variety of aggressive cancers, including hepatocellular cancer and non-small cell lung adenocarcinoma [27, 39]. Here, ERCC6L is linked to cancer.